114 related articles for article (PubMed ID: 37464878)
1. Radiopharmaceutical extravasation in bone scintigraphy: a cross-sectional study.
Fernandes D; Santos M; Pinheiro M; Duarte H; Fontes F
Nucl Med Commun; 2023 Oct; 44(10):870-875. PubMed ID: 37464878
[TBL] [Abstract][Full Text] [Related]
2. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
Higashiyama S; Yoshida A; Kawabe J
Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
[TBL] [Abstract][Full Text] [Related]
3. Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing
Parihar AS; Schmidt LR; Crandall J; Dehdashti F; Wahl RL
J Nucl Med; 2023 Mar; 64(3):485-490. PubMed ID: 36265907
[TBL] [Abstract][Full Text] [Related]
4. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
9. Osteoblastic osteosarcoma of the mandible: findings on Tc-99m HMDP bone and Ga-67 citrate scintigraphy.
Takahashi T; Oguchi M; Kuga G; Higashi K; Tonami H; Yamamoto I; Segami N; Nojima T
Clin Nucl Med; 2005 Sep; 30(9):608-9. PubMed ID: 16100479
[TBL] [Abstract][Full Text] [Related]
10. Splenic accumulation of Tc-99m HMDP in a patient with severe alcoholic cirrhosis of the liver.
Kawamura E; Kawabe J; Hayashi T; Oe A; Kotani J; Torii K; Habu D; Shiomi S
Clin Nucl Med; 2005 May; 30(5):351-2. PubMed ID: 15827413
[TBL] [Abstract][Full Text] [Related]
11. Alternative Isotope Options for Amyloidosis Imaging: A Technologist's Perspective.
Warren J
J Nucl Med Technol; 2023 Jun; 51(2):117-119. PubMed ID: 37192821
[TBL] [Abstract][Full Text] [Related]
12. A Reversible Gastric Uptake of Bone Scintigraphy in a Patient with Hypercalcemia.
Fukasawa H; Ide S; Kaneko M; Ishibuchi K; Niwa H; Yasuda H; Furuya R
Intern Med; 2019 Jun; 58(11):1583-1586. PubMed ID: 30713296
[TBL] [Abstract][Full Text] [Related]
13. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
14. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
Higashiyama S; Yoshida A; Kawabe J
Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
[TBL] [Abstract][Full Text] [Related]
15. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
[TBL] [Abstract][Full Text] [Related]
18. Incidental finding of varicocele detected on a blood-pool image on Tc-99m HMDP bone scintigraphy.
Minoves M; Bassa P; Clemente A; Rivas A; Riera E; Setoain J; Costansa JM
Clin Nucl Med; 2000 Nov; 25(11):947-8. PubMed ID: 11079610
[No Abstract] [Full Text] [Related]
19. Three-phase bone scintigraphy in chronic epicondylitis.
Pienimäki TT; Takalo RJ; Ahonen AK; Karppinen JI
Arch Phys Med Rehabil; 2008 Nov; 89(11):2180-4. PubMed ID: 18996248
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-depreotide in the evaluation of bone infection and inflammation.
Papathanasiou ND; Rondogianni PE; Pianou NK; Karampina PA; Vlontzou EA; Datseris IE
Nucl Med Commun; 2008 Mar; 29(3):239-46. PubMed ID: 18349794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]